BIG
LEGN icon

Brooklyn Investment Group’s Legend Biotech LEGN Stock Holding History

Brooklyn Investment Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$382K Buy
21,095
+2,356
+13% +$44.9K 0.01% 1234
2025
Q4 		$411K Buy
+18,739
New +$537K 0.02% 812
2025
Q3 		– Sell
-2,586
Closed -$91.8K – 1790
2025
Q2 		$91.8K Buy
2,586
+861
+50% +$27.9K 0.01% 985
2025
Q1 		$58.5K Buy
1,725
+1,583
+1,115% +$56.8K 0.01% 719
2024
Q4 		$4.62K Buy
+142
New +$5.88K ﹤0.01% 1242

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Brooklyn Investment Group's LEGN Position: Q1 2026 in Review

Brooklyn Investment Group increased its Legend Biotech (LEGN) stake by 13% in Q1 2026, buying an estimated $44.9K and bringing the position to 21,095 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #1234.

Brooklyn Investment Group first reported a position in LEGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $411K in Q4 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Brooklyn Investment Group held 21,095 shares of Legend Biotech worth $382K as of Q1 2026.
  • Brooklyn Investment Group bought 2,356 Legend Biotech shares in Q1 2026, an estimated $44.9K.
  • Legend Biotech made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1234 holding.
  • Brooklyn Investment Group first reported a position in Legend Biotech in Q4 2024 and has held it in 5 quarters since.
  • Brooklyn Investment Group's Legend Biotech position peaked at $411K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.